Market

Ratio Analysis

You can view the Ratio Analysis for the last 5 years.

RATIOS

Aristo Bio-Tech and Lifescience Ltd.

GO
Market Cap. ( ₹ in Cr. ) 81.39 P/BV 2.18 Book Value ( ₹ ) 54.84
52 Week High/Low ( ₹ ) 164/85 FV/ML 10/1600 P/E(X) 20.03
Book Closure 15/09/2023 EPS ( ₹ ) 5.97 Div Yield (%) 0.00

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)5.975.726.722.932.15
Diluted EPS (Rs.)5.975.726.722.932.15
Cash EPS (Rs.)9.798.037.495.133.65
Book Value[Excl.RevalReserv]/Share (Rs.)54.8449.3744.3029.7126.79
Book Value[Incl.RevalReserv]/Share (Rs.)54.8449.3744.3029.7126.79
Dividend / Share (Rs.)0.000.400.250.000.00
Revenue From Operations / Share (Rs.)467.25360.10320.01332.31334.77
PBDIT / Share (Rs.)14.2912.7413.2611.028.72
PBIT / Share (Rs.)10.4710.4311.018.827.22
PBT / Share (Rs.)8.037.946.964.093.00
Net Profit / Share (Rs.)5.975.725.232.932.15
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)3.053.534.143.312.60
PBIT Margin (%)2.232.893.432.652.15
PBT Margin (%)1.712.202.171.220.89
Net Profit Margin (%)1.271.581.630.880.64
Return on Networth / Equity (%)10.8811.5911.819.848.03
Return on Capital Employeed (%)15.8116.2418.5716.9114.17
Return On Assets (%)2.883.063.561.891.32
Long Term Debt / Equity (X)0.200.290.330.740.90
Total Debt / Equity (X)0.580.620.741.721.66
Asset Turnover Ratio (%)2.372.162.462.101.97
      
LIQUIDITY RATIOS     
      
Current Ratio (X)1.211.261.401.231.23
Quick Ratio (X)0.710.770.870.740.66
Inventory Turnover Ratio (X)6.756.297.194.924.40
Dividend Payout Ratio (NP) (%)0.0011.350.000.000.00
Dividend Payout Ratio (CP) (%)0.008.090.000.000.00
Earning Retention Ratio (%)0.0088.650.000.000.00
Cash Earning Retention Ratio (%)0.0091.910.000.000.00
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)5.875.123.282.332.07
Interest Coverage Ratio (Post Tax) (%)3.453.302.291.621.51
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)99.8562.7558.800.000.00
EV / Net Operating Revenue (X)0.310.250.260.000.00
EV / EBITDA (X)10.267.246.510.000.00
MarketCap / Net Operating Revenue (X)0.240.170.170.000.00
Retention Ratios (%)0.0088.640.000.000.00
Price / BV (X)2.121.261.270.000.00
Price / Net Operating Revenue (X)0.240.170.170.000.00
EarningsYield0.050.090.090.000.00